New aspects of the therapeutic influence of sludging in internal diseases and some critical remarks concerning the effectiveness of low molecular weight dextran.
D001161:Arteriosclerosis / Q000097:blood*; D001799:Blood Sedimentation; D002986:Clinical Trials as Topic; D003228:Conjunctiva / Q000098:blood supply; D003911:Dextrans / Q000494:pharmacology / Q000627:therapeutic use*; D004903:Erythrocyte Aggregation / Q000188:drug therapy* / Q000209:etiology; D006400:Hematocrit; D006801:Humans; D008833:Microcirculation / Q000187:drug effects; D008970:Molecular Weight; D013514:Surgical Procedures, Operative
D003911:Dextrans